Acute pharmacological degradation of Helios destabilizes regulatory T cells

By Eric S. Wang, Alyssa L Verano, R. Nowak, J. C. Yuan, K. Donovan, N. Eleuteri, Hong Yue, K. Ngo, P. Lizotte, P. Gokhale and 2 more. 2021

97 citations recorded by the source corpus.

The zinc-finger transcription factor Helios is critical for maintaining the identity, anergic phenotype and suppressive activity of regulatory T (Treg) cells. While it is an attractive target to enhance the efficacy of currently approved immunotherapies, no existing approaches can directly modulate Helios activity or abundance. Here, we report the structure-guided development of small molecules that recruit the E3 ubiquitin ligase substrate receptor cereblon to Helios, thereby promoting its degradation. Pharmacological Helios degradation destabilized the anergic phenotype and reduced the suppressive activity of Treg cells, establishing a route towards Helios-targeting therapeutics. More generally, this study provides a framework for the development of small-molecule degraders for previously unligandable targets by reprogramming E3 ligase substrate specificity. Two degraders targeting zinc finger transcription factor IKZF2 (Helios) were developed by reprogramming CRL4CRBN E3 ligase, and the pharmacologic degradation of Helios results in Treg destabilization.

Subfields: Immunology, Molecular Biology, Oncology